Correlation Between Protagenic Therapeutics and Akzo Nobel

Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Akzo Nobel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Akzo Nobel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagenic Therapeutics and Akzo Nobel NV, you can compare the effects of market volatilities on Protagenic Therapeutics and Akzo Nobel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Akzo Nobel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Akzo Nobel.

Diversification Opportunities for Protagenic Therapeutics and Akzo Nobel

-0.39

Correlation Coefficient

Protagenic Therapeutics  Akzo Nobel

Very good diversification

The 3 months correlation between Protagenic and Akzo is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Akzo Nobel NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akzo Nobel NV and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Akzo Nobel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akzo Nobel NV has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Akzo Nobel go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Akzo Nobel

Assuming the 90 days horizon Protagenic Therapeutics is expected to generate 19.9 times more return on investment than Akzo Nobel. However, Protagenic Therapeutics is 19.9 times more volatile than Akzo Nobel NV. It trades about 0.14 of its potential returns per unit of risk. Akzo Nobel NV is currently generating about -0.27 per unit of risk. If you would invest  0.90  in Protagenic Therapeutics on September 1, 2024 and sell it today you would earn a total of  0.05  from holding Protagenic Therapeutics or generate 5.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	33.33%
Values	Daily Returns

Protagenic Therapeutics  vs.  Akzo Nobel NV

Protagenic Therapeutics

Risk-Adjusted Performance

0 of 100

Solid

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Akzo Nobel NV

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Akzo Nobel NV are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Akzo Nobel is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Protagenic Therapeutics and Akzo Nobel

The main advantage of trading using opposite Protagenic Therapeutics and Akzo Nobel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Akzo Nobel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akzo Nobel will offset losses from the drop in Akzo Nobel's long position.

The idea behind Protagenic Therapeutics and Akzo Nobel NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.